Waqoo Inc.
4937・Growth Market・Chemicals
Waqoo Inc.4937
Waqoo Inc.4937
Reference Indicators
Market Cap
55¥100M
P/E (Forecast)
21.9x
P/B
2.5x
Dividend Yield (Forecast)
0.00%
ROE
2.1%
EV/EBITDA
17.1x
Financial Summary
Unit: ¥M
| Item | 2021Sep 2021 | 2022Sep 2022 | 2023Sep 2023 | 2024Sep 2024 | 2025Sep 2025 |
|---|---|---|---|---|---|
Net Sales | 4,684 | 2,731 | 1,726 | 1,943 | 1,960 |
Cost of Sales | 902 | 801 | 414 | 393 | 401 |
Gross Profit | 3,781 | 1,929 | 1,311 | 1,549 | 1,559 |
SG&A Expenses | 3,630 | 1,969 | 1,033 | 1,493 | 1,408 |
Operating Income | 149 | -39 | 277 | 56 | 150 |
Non-operating Income | 5 | 24 | 13 | 6 | 13 |
Non-operating Expenses | 14 | 6 | 3 | 5 | 11 |
Ordinary Income | 140 | -21 | 287 | 57 | 152 |
Extraordinary Losses | — | — | 253 | — | — |
Pre-tax Income | 140 | -21 | 34 | 57 | 152 |
Income Taxes | 24 | 35 | 5 | 74 | 108 |
Net Income | 116 | -57 | 28 | -17 | 44 |
EBITDA | 155 | -33 | 284 | 160 | 286 |
Gross Margin | 80.7% | 70.6% | 76.0% | 79.7% | 79.5% |
Operating Margin | 3.2% | -1.5% | 16.1% | 2.9% | 7.7% |
ROA | 6.1% | -3.7% | 1.8% | -0.6% | 1.4% |
ROE | 24.1% | -7.7% | 3.7% | -0.8% | 2.1% |
Segment Performance
Unit: ¥M
2025
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| D2C事業 | 952 | 294 | 30.9% |
| メディカルサポート事業 | 999 | 216 | 21.6% |